Inhibition of Plasmodium falciparum choline kinase by hexadecyltrimethylammonium bromide: a possible antimalarial mechanism
about
The metabolic advantage of tumor cellsEqual opportunity for low-degree network nodes: a PageRank-based method for protein target identification in metabolic graphsHuman Choline Kinase-α Promotes Hepatitis C Virus RNA Replication through Modulation of Membranous Viral Replication Complex FormationComparison of the cellular and biochemical properties of Plasmodium falciparum choline and ethanolamine kinasesIdentification and molecular characterization of an Alba-family protein from human malaria parasite Plasmodium falciparumIdentification of small molecule lead compounds for visceral leishmaniasis using a novel ex vivo splenic explant model systemThe diamidine DB75 targets the nucleus of Plasmodium falciparumAntimalarial drug targets in Plasmodium falciparum predicted by stage-specific metabolic network analysisIdentification of inhibitors for putative malaria drug targets among novel antimalarial compounds.Choline Kinase Alpha as an Androgen Receptor Chaperone and Prostate Cancer Therapeutic Target.The ethanolamine branch of the Kennedy pathway is essential in the bloodstream form of Trypanosoma brucei.Novel antimalarial drug targets: hope for new antimalarial drugs.Antimalarial Activity of Small-Molecule Benzothiazole Hydrazones.Antiplasmodial activity and mechanism of action of RSM-932A, a promising synergistic inhibitor of Plasmodium falciparum choline kinase.Antiplasmodial activity of [(aryl)arylsulfanylmethyl]Pyridine.Functional interrogation of Plasmodium genus metabolism identifies species- and stage-specific differences in nutrient essentiality and drug targeting.Effects of miltefosine treatment in fibroblast cell cultures and in mice experimentally infected with Neospora caninum tachyzoites.
P2860
Q21245765-0018BEB9-64EC-4DE9-A57B-02BD7F5B515CQ21559702-72648B7D-E1C4-413E-BF77-9DB0253C4C06Q27468561-8F8F863C-9723-4121-834C-F85594F569EBQ27972958-2CF17AC1-0BDA-403E-8D70-E25592BE5E7CQ27973678-507D5DFE-B12D-4B47-A8B5-9950EC8F26A4Q28477163-26B558D4-C90D-47C2-AED9-DDFBED22462DQ30487931-C9F2949D-A8C2-447D-9ADE-DD3BDBDA6309Q33679330-FAA9492E-ECE7-4390-9C32-7BD63A2EF9DCQ33682916-3D3FA176-219F-42AB-B2FD-4EFB50C03C25Q36849142-60156399-2F96-402C-B2D1-75943CA38B52Q37444934-F7CD3C64-C8BD-49E4-B2CE-A7986A044F1BQ37960187-479CB1A4-4FC5-48CB-A41D-870419F47D6BQ40690139-22BD674D-7FDE-4D08-848A-5BE7A5BE5801Q41882652-362092FB-BD29-4141-AA0C-10A2272624E1Q41886196-72EEE847-B6E4-406E-A90F-0DE4AEAC3DF2Q47200755-1176D88E-771C-4E29-9DC0-B0A35DD9B21DQ51362513-742DAE70-DA3F-425D-85FF-79C8960DF842
P2860
Inhibition of Plasmodium falciparum choline kinase by hexadecyltrimethylammonium bromide: a possible antimalarial mechanism
description
2007 nî lūn-bûn
@nan
2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Inhibition of Plasmodium falci ...... ossible antimalarial mechanism
@ast
Inhibition of Plasmodium falci ...... ossible antimalarial mechanism
@en
Inhibition of Plasmodium falci ...... ossible antimalarial mechanism
@nl
type
label
Inhibition of Plasmodium falci ...... ossible antimalarial mechanism
@ast
Inhibition of Plasmodium falci ...... ossible antimalarial mechanism
@en
Inhibition of Plasmodium falci ...... ossible antimalarial mechanism
@nl
prefLabel
Inhibition of Plasmodium falci ...... ossible antimalarial mechanism
@ast
Inhibition of Plasmodium falci ...... ossible antimalarial mechanism
@en
Inhibition of Plasmodium falci ...... ossible antimalarial mechanism
@nl
P2093
P2860
P921
P3181
P356
P1476
Inhibition of Plasmodium falci ...... ossible antimalarial mechanism
@en
P2093
Kumkum Srivastava
Mithu Guha
Sanjay Kumar
Sunil Kumar Puri
Uday Bandyopadhyay
P2860
P304
P3181
P356
10.1128/AAC.00919-06
P407
P577
2007-02-01T00:00:00Z